Dyslipoproteinemia in pediatric systemic lupus erythematosus

Arthritis & Rheumatism

Volumn 31, Issue 7, 1988, Pages 859-863

  Ilowite, Norman T ^a,b,c,d   Samuel, Paul ^a,b,d   Ginzler, Ellen ^a,b,d   Jacobson, Marc S ^a,b,d  

^a STONY BROOK UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^d LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADOLESCENT; ARTERIOSCLEROSIS; CLINICAL ARTICLE; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; MALE; PEDIATRICS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHOLESTEROL; HUMAN; LIPOPROTEINS; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; LIPOPROTEINS, VLDL; LIPOPROTEINS, VLDL CHOLESTEROL; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISONE; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0023792957     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780310706     Document Type: Article

References (44)

1. Childhood systemic lu erythematosus
2. Myocardial infarct in a child systemic lupus erythematosus
3. Myocardial infarction due to coronary atheroscleros three young adults with systemic lupus erythemato
4. Myocardial infarction in young patients with systemic lupus erythematosu
5. Ischemic heart disease in systemic lupus erythe tosus in the young patient: report of six cases
6. Coronary arterial disease systemic lupus erythematosus: qualification of deg of narrowing in 22 necropsy patients (21 women) age to 37 years
7. Cerebral inf tion associated with lupus anticoagulants: prelimin report
8. Thrombosis in systemic lupus ery matosus: striking association with the presence of cir lating lupus anticoagulant
9. Dyslipoproteinemia in systemic lu erythematosus
10. The 1982 revised criteria for the classification of systemic lupus erythematosus
11. New micromethod for measuring cholesterol in plasma lipoprotein fraction
12. Quantitative determination of serum triglycerides by the use of enzymes
13. Dextran sulfate‐Mg2+ precipitation procedure for quantitative determination of high density‐lipoprotein cholesterol
14. Measurement of apolipoprotein A‐1 concentration in nonhuman primate serum by enzyme‐linked immunosorbent assay
15. The relation of apolipoproteins A‐I and B in children to parental myocardial infarction
16. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relation to inflammatory activity
17. Relation of serum lipids and lipoproteins to fatty liver in Kwashiorkor
18. Metabolic abnormalities in adolescent patients with anorexia nervosa
19. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia
20. The hyperlipidemia of the nephrotic syndrome: relation to plasma albumin concentration, oncotic pressure and viscosity
21. Autoimmune hyperlipidemia
22. Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance
23. Systemic lupus erythematosus in childhood presenting as hyperlipoproteinemia
24. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus
25. Receptor mediated pathway for cholesterol homeostasis
26. Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk
27. Hypertriglyceridemia associated with deficiency of apolipoprotein C‐II
28. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3‐L1 cells
29. Purification of cachectin, a lipoprotein lipase‐suppressing hormone secreted by endotoxin‐induced raw 264.7 cells
30. Recombinant γ‐interferon induces hypertriglyceridemia and inhibits post‐heparin lipase activity in cancer patients
31. Immune interferon in the circulation of patients with autoimmune diseases
32. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis
33. Systemic lupus erythematosus in human serum of an unusual acid‐labile leukocyte interferon
34. Characterization of amyloid related protein SAA complexed with serum lipoproteins
35. Rapid clearance of serum amyloid A from high density lipoproteins
36. Adrenocortical steroid treatment of rheumatic diseases: effects on lipid metabolism
37. The effects of prednisone therapy on plasma, lipoproteins and apolipoproteins: a prospective study
38. Cholesterol and coronary heart disease: a new era
39. Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression
40. Consensus Conference: Lowering blood cholesterol to prevent heart disease
41. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study
42. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients
43. Renal involvement in systemic lupus erythematosus: a study of 56 patients emphasizing histologic classification